Physician

Aferdita Spahillari

According to 2025 Medicare claims, Aferdita Spahillari (NPI: 1891010187) practices advanced heart failure and transplant cardiology in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Durham, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27705-4699. Spahillari is affiliated with the Duke Connected Care, LLC (ACO ID: A2419), Mass General Brigham ACO, LLC (ACO ID: A4641), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Spahillari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 351 traditional Medicare patients, billed 1,338 HCPCS/CPT codes, and received $71,298 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 702 prescription claims across 152 beneficiaries totaling $229,216 in drug costs, led by Entresto (Sacubitril/Valsartan). 2017 DME data shows 39 claims. Open Payments data shows 1 records totaling $2,140. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $6,479 to $229,216. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	243	511	$33,213
2018	737	1,620	$121,287
2019	709	1,498	$100,761
2020	565	1,049	$76,404
2021	530	1,171	$91,993
2022	715	1,435	$99,294
2023	512	1,130	$76,237
2024	351	1,338	$71,298

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	27	138	$6,479
2016	29	114	$5,818
2017	61	202	$9,502
2018	105	537	$46,389
2019	112	659	$120,088
2020	108	692	$315,030
2021	107	879	$354,165
2022	118	887	$753,989
2023	111	609	$546,105
2024	152	702	$229,216

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	39	$2,593
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	59	193	$82
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	139	141	$73
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	73	238	$55
76377	3d radiographic procedure with computerized image postprocessing	69	69	$35
93356	Heart muscle strain imaging	108	109	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	104	5,242	$114,332
Jardiance	Empagliflozin	61	3,284	$61,116
Farxiga	Dapagliflozin Propanediol	24	1,140	$20,641
Eliquis	Apixaban	19	810	$14,915
Spironolactone	Spironolactone	111	6,684	$824

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$2,140	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aferdita Spahillari?

Tedicare shows public-source Medicare data for Aferdita Spahillari (NPI 1891010187), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aferdita Spahillari have ACO affiliation data?

Aferdita Spahillari is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419), Mass General Brigham ACO, LLC (MSSP, ACO ID A4641), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Aferdita Spahillari?

Aferdita Spahillari is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Aferdita Spahillari have Open Payments data?

Aferdita Spahillari has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.